These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23083522)

  • 1. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
    Eur J Radiol; 2013 Feb; 82(2):366-73. PubMed ID: 23083522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
    Shen G; Zhang W; Jia Z; Li J; Wang Q; Deng H
    Br J Radiol; 2014 Dec; 87(1044):20140296. PubMed ID: 25348201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
    Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
    Eur J Radiol; 2012 Nov; 81(11):3511-7. PubMed ID: 22305013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis.
    Xu GZ; Zhu XD; Li MY
    Head Neck; 2011 Jan; 33(1):87-94. PubMed ID: 20848421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Lin CY; Chen JH; Liang JA; Lin CC; Jeng LB; Kao CH
    Eur J Radiol; 2012 Sep; 81(9):2417-22. PubMed ID: 21899970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of whole-body [
    Mirshahvalad SA; Kohan A; Metser U; Hinzpeter R; Ortega C; Farag A; Veit-Haibach P
    Eur Radiol; 2024 Jan; 34(1):673-685. PubMed ID: 37535156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
    Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G
    Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
    Lu YY; Chen JH; Ding HJ; Chien CR; Lin WY; Kao CH
    Nucl Med Commun; 2012 Nov; 33(11):1127-33. PubMed ID: 23000829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
    Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients.
    Chen YK; Su CT; Ding HJ; Chi KH; Liang JA; Shen YY; Chen LK; Yeh CL; Liao AC; Kao CH
    Anticancer Res; 2006; 26(2B):1471-7. PubMed ID: 16619560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients.
    Li J; Xu W; Kong F; Sun X; Zuo X
    Surg Oncol; 2013 Sep; 22(3):151-5. PubMed ID: 23664848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.